Stocks
Erasca, Inc.ERAS
NASDAQHealthcareBiotechnology$14.67
Focused on precision oncology, the company develops targeted therapies for cancers driven by mutations in the RAS/MAPK signaling pathway. Its pipeline consists primarily of small‑molecule inhibitors and combination strategies aimed at difficult‑to‑treat solid tumors, with several candidates in clini...
52W Range: $1.01 – $16.41
Congressional Interest in Erasca, Inc. (ERAS)
No congressional trades have been disclosed for Erasca, Inc. (ERAS) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ERAS?
No congressional trades found for this stock.